在帕金森病中重复眼
Varsha Vasudevan1, Quentin Salardaine2, Sophie Rivaud-Péchoux2
1INSERM U1127, CNRS UMR7225, UM75, Movement Investigation and Therapeutics Team, Paris Brain Institute, ICM, Sorbonne Université, Paris, France. varsha.vd.gupta@gmail.com.
Scientific reports
|March 29, 2025
概括
帕金森病 (PD) 患者的眼速度较慢,眼持续时间较长. 眼频率与运动症状和多巴胺损失相关,而眼持续时间与嗜睡有关,这表明眼分析有助于诊断PD.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 神经学 神经学
背景情况:
- 自发眼,一种无意识的反射,与认知功能和多巴胺相关的活动有关.
- 减少自发眼率是帕金森病 (PD) 的已知特征.
- 眼速率作为认知处理和多巴胺功能的生物标志物.
研究的目的:
- 研究眼持续时间作为帕金森病的新特性.
- 为了评估一大批PD患者眼率和眼持续时间的变化.
- 探索眼特征和PD严重程度之间的相关性,包括运动缺陷和多巴胺能神经元损失.
主要方法:
- 在107名帕金森病患者和健康对照中分析自发眼率和眼持续时间.
- 评估眼特征与临床疾病特征之间的关系.
- 与多巴胺载体条状结合比率的相关性分析,以量化多巴胺基耗尽.
主要成果:
- 与对照组相比,帕金森病患者的闪率显著降低,闪时间增加.
- 闪率与运动缺陷严重程度和条状多巴胺载体结合相关.
- 眼的持续时间与非运动性症状有关,特别是嗜睡.
结论:
- 眼频率和眼持续时间在帕金森病中发生变化,反映了该病的运动和非运动方面.
- 眼的特征显示出潜在的帕金森病的区分特征.
- 将眼评估纳入眼运动测试协议中,可以提高PD诊断和监测.
相关概念视频
Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26
Alterations in Muscle Tone lll
28
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
28


